Nefrologia

Consenso | Adequação de critérios para avaliação e prevenção de dano renal no paciente submetido a exames com contraste.

24 Mar, 2022 | 12:16h

SIRM-SIN-AIOM: appropriateness criteria for evaluation and prevention of renal damage in the patient undergoing contrast medium examinations—consensus statements from Italian College of Radiology (SIRM), Italian College of Nephrology (SIN) and Italian Association of Medical Oncology (AIOM) – La radiologia medica

Conteúdos relacionados:

Another study shows intravenous radiocontrast use is not associated with reduced kidney function

ACR/NKF Consensus Statement: “The Risk of Acute Kidney Injury Developing in Patients with Reduced Kidney Function Following Exposure to Intravenous Iodinated Contrast Media has Been Overstated”

---

Editorial | Transplantes porco-humano dão um salto em direção à realidade.

23 Mar, 2022 | 11:43h

Pig-to-human transplants take a leap toward reality – Nature Medicine

---

Propiciando a escolha do paciente: a opção de “decidir por não decidir” para idosos diante de decisões relacionadas à diálise.

23 Mar, 2022 | 11:40h

Enabling Patient Choice: The “Deciding Not to Decide” Option for Older Adults Facing Dialysis Decisions – Journal of the American Society of Nephrology

Comentário: The “Deciding Not to Decide” Option Can Improve Older Adult Patient Care – Rutgers University-New Brunswick

---

Atualização | Hipertensão no paciente internado.

21 Mar, 2022 | 16:21h

Hypertension in the hospitalized patient: An update – Nefrología

---

[Comunicado de imprensa – ainda não publicado] Estudo EMPA-KIDNEY de fase III sobre empaglifozina será interompido precocemente em razão de evidência da eficácia em pessoas com doença renal crônica.

17 Mar, 2022 | 13:16h

Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease – Lilly

Ver também: Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial – Nephrology Dialysis Transplantation

 

Comentário no Twitter

Details of the design & pt characteristics now published:

6609 people from 8 countries
(UK, Germany, Italy, USA, Canada, China, Malaysia, Japan)
Mean age 64 years
1/3 female
1/2 diabetes; 1/2 without
3/4 eGFR <45 mL/min/1.73 m2.
1/2 uACR <300 mg/g https://t.co/jOD8kyp3i4 pic.twitter.com/YYpGPJDnV9

— Martin Landray (@MartinLandray) March 16, 2022

 

---

Hipertensão maligna: perspectivas atuais e desafios.

17 Mar, 2022 | 13:12h

Malignant Hypertension: Current Perspectives and Challenges – Journal of the American Heart Association

---

Podcast | Dicas sobre síndrome cardiorrenal.

15 Mar, 2022 | 12:57h

#326 NephMadness 2022: Cardiorenal Syndrome – The Curbsiders

---

Revisão sistemática | Desfechos de longo prazo entre pacientes com doença renal avançada que renunciam à diálise de manutenção.

15 Mar, 2022 | 12:53h

Long-term Outcomes Among Patients With Advanced Kidney Disease Who Forgo Maintenance Dialysis: A Systematic Review – JAMA Network Open

Comentários:

Conservative Care for Kidney Failure—The Other Side of the Coin – JAMA Network Open

Study: Advanced kidney disease patients can survive, with quality life, without dialysis – UPI

---

Revisão sistemática | Agentes antiplaquetários para doença renal crônica.

11 Mar, 2022 | 14:47h

Antiplatelet agents for chronic kidney disease – Cochrane Library

---

Série de casos e revisão da literatura | Nefropatia por bisfosfonatos.

9 Mar, 2022 | 13:25h

Bisphosphonate nephropathy: A case series and review of the literature – British Journal of Clinical Pharmacology

---